These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
612 related items for PubMed ID: 16387581
1. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk. Murphy S, Roberts R. J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581 [Abstract] [Full Text] [Related]
2. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Wysowski DK, Swartz L. Arch Intern Med; 2005 Jun 27; 165(12):1363-9. PubMed ID: 15983284 [Abstract] [Full Text] [Related]
3. Droperidol, QT prolongation, and sudden death: what is the evidence? Kao LW, Kirk MA, Evers SJ, Rosenfeld SH. Ann Emerg Med; 2003 Apr 27; 41(4):546-58. PubMed ID: 12658255 [Abstract] [Full Text] [Related]
4. FDA boxed warnings: how to prescribe drugs safely. O'Connor NR. Am Fam Physician; 2010 Feb 01; 81(3):298-303. PubMed ID: 20112888 [Abstract] [Full Text] [Related]
5. National adverse drug reaction reporting. 1984-1989. Faich GA. Arch Intern Med; 1991 Aug 01; 151(8):1645-7. PubMed ID: 1872669 [Abstract] [Full Text] [Related]
6. How the FDA manages drug safety with black box warnings, use restrictions, and drug removal, with attention to gastrointestinal medications. Ehrenpreis ED, Ciociola AA, Kulkarni PM, FDA-Related Matters Committee of the American College of Gastroenterology. Am J Gastroenterol; 2012 Apr 01; 107(4):501-4. PubMed ID: 22475958 [No Abstract] [Full Text] [Related]
7. Food and Drug Administration monitoring of adverse drug reactions. Sills JM, Tanner LA, Milstien JB. Am J Hosp Pharm; 1986 Nov 01; 43(11):2764-70. PubMed ID: 3799612 [Abstract] [Full Text] [Related]
15. FDA drug prescribing warnings: is the black box half empty or half full? Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. Pharmacoepidemiol Drug Saf; 2006 Jun 01; 15(6):369-86. PubMed ID: 16294363 [Abstract] [Full Text] [Related]
16. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility. Matlock A, Allan N, Wills B, Kang C, Leikin JB. Clin Toxicol (Phila); 2011 Jul 01; 49(6):443-7. PubMed ID: 21591886 [Abstract] [Full Text] [Related]
20. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs. Wang LM, Wong M, Lightwood JM, Cheng CM. Ann Pharmacother; 2010 Jan 01; 44(1):28-34. PubMed ID: 20040698 [Abstract] [Full Text] [Related] Page: [Next] [New Search]